Publication: A Serial shRNA Screen for Roadblocks to Reprogramming Identifies the Protein Modifier SUMO2
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Borkent, M., B. Bennett, B. Lackford, O. Bar-Nur, J. Brumbaugh, L. Wang, Y. Du, et al. 2016. “A Serial shRNA Screen for Roadblocks to Reprogramming Identifies the Protein Modifier SUMO2.” Stem Cell Reports 6 (5): 704-716. doi:10.1016/j.stemcr.2016.02.004. http://dx.doi.org/10.1016/j.stemcr.2016.02.004.
Research Data
Abstract
Summary The generation of induced pluripotent stem cells (iPSCs) from differentiated cells following forced expression of OCT4, KLF4, SOX2, and C-MYC (OKSM) is slow and inefficient, suggesting that transcription factors have to overcome somatic barriers that resist cell fate change. Here, we performed an unbiased serial shRNA enrichment screen to identify potent repressors of somatic cell reprogramming into iPSCs. This effort uncovered the protein modifier SUMO2 as one of the strongest roadblocks to iPSC formation. Depletion of SUMO2 both enhances and accelerates reprogramming, yielding transgene-independent, chimera-competent iPSCs after as little as 38 hr of OKSM expression. We further show that the SUMO2 pathway acts independently of exogenous C-MYC expression and in parallel with small-molecule enhancers of reprogramming. Importantly, suppression of SUMO2 also promotes the generation of human iPSCs. Together, our results reveal sumoylation as a crucial post-transcriptional mechanism that resists the acquisition of pluripotency from fibroblasts using defined factors.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service